Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference84 articles.
1. Society, A.C. Key statistics for ovarian cancer. 2021 [cited 2021 February 3]; Available from: https://www.cancer.org/cancer/ovarian-cancer/about/key-statistics.
2. Moore K, et al. Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med. 2018;379(26):2495–505.
3. Tew WP, et al. PARP inhibitors in the management of ovarian cancer: ASCO Guideline. J Clin Oncol. 2020;38(30):3468–93.
4. Society, A.C. Key statistics for endometrial cancer. 2021 [cited 2021 February 3]; Available from: https://www.cancer.org/cancer/endometrial-cancer/about/key-statistics.html#:~:text=The%20American%20Cancer%20Society%20estimates,or%20corpus)%20will%20be%20diagnosed.
5. Wang Q, et al. Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence. Signal Transduct Target Ther. 2020;5(1):137.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献